Unleashing Innovation at Boehringer Ingelheim

Pioneering New Medicines Through External Innovation 

Join us at our upcoming seminar and networking event where we'll share our unique approach to fostering innovation and supporting startups. We're excited to introduce you to Research Beyond Borders, our approach to open science: opnMe.com, and we will announce our Innovation Prize 2024 winner.  The event will take place at the Research Institute of Molecular Pathology in Vienna.

Research Beyond Borders 

Research Beyond Borders (RBB) is our ‘radar’ for the next wave of innovation. The RBB team explores disruptive ideas and approaches across the entire research spectrum. Our portfolio covers a diverse disease space, aiming to advance drug discovery in areas of high unmet medical need. More than 80% of RBB´s projects are anchored in external collaborations. Since its foundation in 2015, we've established around 170 partnerships with world-leading universities, academic research institutions, and biotech companies, as well as advanced several collaborative programs to the clinic. 

opnMe 

We believe in the power of sharing and learning. opnMe.com is our dedicated open science initiative that provides free and open access to selected pre-clinical compounds for non-clinical investigation purposes. This initiative helps to maximize the potential for new drug discovery by providing the tools and scientific exchange of knowledge. 

Innovation Prize Vienna 2024 

As part of our Grass Roots initiatives, the Innovation Prize is our way of recognizing the challenge and dedication it takes to start a new company. We award valuable resources to life-science start-ups, allowing them to focus on developing the next generation of breakthrough medicines. 

During our networking event, you can connect with our experts and learn more about these initiatives and how we can support your journey in the life-sciences industry.